Skip to content
10-Q

Quarterly Report

Applied BioSciences Corp.

0001477932-18-005520

← back to feed
Filed
Nov 14, 2018 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Nov 9, 2018 11.77M sh
Current Liabilities Q2 2019 · Sep 30, 2018 $356.39K
Current Liabilities Q2 2019 · Mar 31, 2018 $35.89K
Current Assets Q2 2019 · Sep 30, 2018 $124.12K
Current Assets Q2 2019 · Mar 31, 2018 $226.85K
Total Assets Q2 2019 · Sep 30, 2018 $1.01M
Total Assets Q2 2019 · Mar 31, 2018 $705.33K
Operating Cash Flow Q2 2019 · Sep 30, 2017 −$210.21K
Sga Expense restated Q2 2019 · Sep 30, 2017 $84.62K
Sga Expense restated Q2 2019 · Sep 30, 2017 $223.52K
Net Income Q2 2019 · Sep 30, 2017 −$177.41K
Net Income Q2 2019 · Sep 30, 2017 −$374.61K
Operating Income Q2 2019 · Sep 30, 2017 −$177.41K
Operating Income Q2 2019 · Sep 30, 2017 −$374.61K
Gross Profit Q2 2019 · Sep 30, 2017 $8.84K
Gross Profit Q2 2019 · Sep 30, 2017 $26.22K
Cost Of Revenue Q2 2019 · Sep 30, 2017 $52.44K
Cost Of Revenue Q2 2019 · Sep 30, 2017 $90.39K
Revenue Q2 2019 · Sep 30, 2017 $61.28K
Revenue Q2 2019 · Sep 30, 2017 $116.61K